CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at $3.02 ($6,034)
- 8-K Event Executive or director change
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Agreement ended · Unregistered share sale
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at $3.85 ($7,699)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $3.26 ($6,522)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at $2.80 ($5,598)
- 4 Open-market buy President bought 1,250 shares at $2.79 ($3,487)
- 4 Open-market buy Chief Executive Officer bought 7,000 shares at an average $3.09 ($21,652)
- 4 Open-market buy President bought 1,000 shares at $3.22 ($3,223)
- 4 Open-market buy Chief Executive Officer bought 1,500 shares at $3.05 ($4,570)
- 4 Open-market buy President bought 1,250 shares at $2.90 ($3,622)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 14 of 38 · 753 filings